Stephanie Fulmer-Smentek

Statistics

Publications

Citations

3.7K

H-Index

Active since

2001

Affiliations

Agilent Technologies (United States)(Current)

United States Food and Drug Administration

Illumina (United States)

National Center for Toxicological Research

Center for Drug Evaluation and Research

Stephanie Fulmer-Smentek is an author at Agilent Technologies (United States) specializing in molecular biology, life sciences, and gene expression analysis.

Publications per year

2001–2014

Publications

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

Leming Shi, Leming Shi, Laura Reid et al. · Nature Biotechnology · 2006 · 2.2K citations

Life Sciences, Bioinformatics, Molecular Biology +15

Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study

Pieter Mestdagh, Nicole Hartmann, Lukas Baeriswyl et al. · Nature Methods · 2014 · 637 citations

Life Sciences, Bioinformatics, Molecular Biology +11

Performance comparison of one-color and two-color platforms within the Microarray Quality Control (MAQC) project

Tucker A. Patterson, Edward K. Lobenhofer, Stephanie Fulmer-Smentek et al. · Nature Biotechnology · 2006 · 515 citations

Life Sciences, Bioinformatics, Molecular Biology +6

Using RNA sample titrations to assess microarray platform performance and normalization techniques

Richard Shippy, Stephanie Fulmer-Smentek, Roderick V. Jensen et al. · Nature Biotechnology · 2006 · 177 citations

Life Sciences, Bioinformatics, Molecular Biology +16

mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities

Hongfang Liu, Petula D'Andrade, Stephanie Fulmer-Smentek et al. · Molecular Cancer Therapeutics · 2010 · 144 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

1–5 of 7